R0.6C transmission blocking vaccine (Novavax/Radboud University)
N/A
Report date: 2023/01/07 17:46:10
Base Information
Drug NameR0.6C transmission blocking vaccine (Novavax/Radboud University)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRadboud University Medical Center
China Registration ClassN/A
Develop Information
Active CompaniesRadboud University Medical CenterRadboud University Nijmegen
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A